Chronic myeloid leukemia (CML) is primarily driven by the Philadelphia (Ph) chromosome, resulting from a translocation that fuses the BCR and ABL genes, producing the BCR-ABL1 fusion protein with enhanced tyrosine kinase activity [3,4]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.